Literature DB >> 1446896

Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats.

T Hirano1, N Kaplowitz, H Tsukamoto, S Kamimura, J C Fernandez-Checa.   

Abstract

Long-term ethanol feeding has been shown to selectively reduce hepatic mitochondrial glutathione content by impairing mitochondrial uptake of this thiol. In this study, we assessed the role of this defect in evolution of alcoholic liver disease by examining the mitochondrial glutathione pool and lipid peroxidation during progression of experimental alcoholic liver disease to centrilobular liver necrosis and fibrosis. Male Wistar rats were intragastrically infused with a high-fat diet plus ethanol for 3, 6 or 16 wk (the duration that resulted in induction of liver steatosis, necrosis and fibrosis, respectively). During this feeding period, the cytosolic pool of glutathione remained unchanged in the ethanol-fed animals compared with that in pair-fed controls. In contrast, the mitochondrial pool of glutathione selectively and progressively decreased in rats infused with ethanol for 3, 6 or 16 wk, by 39%, 61% and 85%, respectively. Renal mitochondrial glutathione level remained unaffected throughout the experiment. Serum ALT levels increased significantly in the ethanol-fed rats at 6 wk and remained elevated at 16 wk. In the mitochondria with severely depleted glutathione levels at 16 wk, enhanced lipid peroxidation was evidenced by increased malondialdehyde levels. Thus a progressive and selective depletion of mitochondrial glutathione is demonstrated in the liver in this experimental model of alcoholic liver disease and associated with mitochondrial lipid peroxidation and progression of liver damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446896     DOI: 10.1002/hep.1840160619

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  31 in total

1.  Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease.

Authors:  Xue Shi; Banrida Wahlang; Xiaoli Wei; Xinmin Yin; K Cameron Falkner; Russell A Prough; Seong Ho Kim; Eugene G Mueller; Craig J McClain; Matthew Cave; Xiang Zhang
Journal:  J Proteome Res       Date:  2012-06-21       Impact factor: 4.466

2.  Increased hepatocellular protein carbonylation in human end-stage alcoholic cirrhosis.

Authors:  C T Shearn; D J Orlicky; L M Saba; A H Shearn; Dennis R Petersen
Journal:  Free Radic Biol Med       Date:  2015-10-27       Impact factor: 7.376

3.  Alcoholic hepatitis: should we combine old drugs for better results?

Authors:  Joaquin Cabezas; Ramon Bataller
Journal:  Hepatol Int       Date:  2016-09-15       Impact factor: 6.047

Review 4.  Alcoholic liver disease: mechanisms of injury and targeted treatment.

Authors:  Alexandre Louvet; Philippe Mathurin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

5.  Role of Mitochondria in Alcoholic Liver Disease.

Authors:  Carmen García-Ruiz; Neil Kaplowitz; José C Fernandez-Checa
Journal:  Curr Pathobiol Rep       Date:  2013-09-01

Review 6.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

Review 7.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

Review 8.  Rodent models of alcoholic liver disease.

Authors:  R Goldin
Journal:  Int J Exp Pathol       Date:  1994-02       Impact factor: 1.925

9.  Chronic ethanol consumption causes alterations in the structural integrity of mitochondrial DNA in aged rats.

Authors:  A Cahill; G J Stabley; X Wang; J B Hoek
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

10.  Experimental liver cirrhosis induced by alcohol and iron.

Authors:  H Tsukamoto; W Horne; S Kamimura; O Niemelä; S Parkkila; S Ylä-Herttuala; G M Brittenham
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.